Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Sancai Fengsui Decoction

Phase 2

NNanfang Hospital, Southern Medical University

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[2][1]

Indication

Radiation-Induced Oral MucositisNot yet recruiting

Radiation-Induced Oral MucositisPhase 2

Not yet recruiting

Timeline

Expected Milestones

Q3 2028

Phase 2Not yet recruiting

Radiation-Induced Oral Mucositis

NCT07692997

Clinical

Trials by Indication[1]

Radiation-induced Oral Mucositis1 trial

A Multicenter Randomized Controlled Trial to Evaluate the Rehabilitative Efficacy of Sancai Fengsui Decoction on Radiation-Induced Oral Mucositis.

Not yet recruiting·NNanfang Hospital, Southern Medical University·Phase 2·NCT07692997·126 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Sancai Fengsui Decoction. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Sancai Fengsui Decoction. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Nanfang Hospital, Southern Medical University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Phase 2[1]
Company: NNanfang Hospital, Southern Medical University

Related News